MarketResearch.biz delivers in-depth insights on the global osteoporosis treatment market in its upcoming report titled, “Global Osteoporosis Treatment Market Trends, Applications, Analysis, Growth, and Forecast: 2018 to 2027”. The global drugs market is estimated to register a CAGR of X.X% in terms of value during forecast period 2018–2027. The report offers in-depth insights, revenue details, and other vital information regarding the target market, and the various trends, drivers, restraints, opportunities, and threats till 2027. The report offers insightful and detailed information regarding the various key players operating in the market, their financials, supply chain trends, technological innovations, key developments, apart from future strategies, acquisitions & mergers, and market footprint. The global osteoporosis treatment market report has been segmented on the product type, distribution channel, route of administration, and region.
This report is based on synthesis, analysis, and interpretation of information gathered regarding the target market from various sources. Our analysts have the information and data and gained insights using a mix of primary and secondary research efforts with the primary objective to provide a holistic view of the market. In addition, an in-house study has been made of the global economic conditions and other economic indicators and factors to assess their respective impact on the market historically, as well as the current impact in order to make informed forecasts about the scenarios in future.
Osteoporosis is a condition wherein bones lose their strength and are more likely to break. Osteoporosis is also a term used to describe low bone density as measured on a bone density (DXA) scan. Furthermore, women are more susceptible to osteoporosis because bone loss becomes faster for several years after the menopause. Osteoporosis treatment is focused on slowing down or stopping the mineral loss. It increases bone density, prevents bone fractures, thereby controls pain associated with the disease.
Increasing number of cases of osteoporosis is turn is expected to support growth of global osteoporosis treatment market over the forecast period. Rapidly growing ageing population is one of the major factor expected to support growth of the global market. Companies focusing on developing innovative and novel osteoporosis treatment methods is expected to boost the growth of the market over the forecast period. In addition, increasing number of approval for osteoporosis treatment drugs by several health authorities is other factor expected to support growth of the market.
North America market dominates the global osteoporosis treatment market in terms of revenue contribution as compared to that of markets in other regions. This is attributed to presence of well-developed healthcare infrastructure coupled with increasing number of product launches in the region. Europe accounts for second-largest revenue share contribution to the global nasal drug delivery systems market, followed by markets in the Asia Pacific, Latin America, and the Middle East & Africa respectively. The market in the Asia Pacific is projected to register comparatively faster growth in terms of revenue over the next 10 years. Rapidly developing healthcare industry coupled with increasing strategic collaboration of international players with domestic companies in order to expand its market presence in the region are factors supporting growth of the market in region over the forecast period.
Target audience for the global osteoporosis treatment market includes osteoporosis drug manufacturers, suppliers of osteoporosis drug, research institutes, and government organizations etc.
Global osteoporosis treatment market segmentation, by product type:
- Hormone Therapy
- Selective Estrogen Receptor Modulators (SERMs)
- Parathyroid Hormone-Related Protein (PTHrP) Analog
- Rank Ligand (RANKL) Inhibitor
Global osteoporosis treatment market segmentation, by route of administration:
Global osteoporosis treatment market segmentation, by distribution channel:
- Online Pharmacies
- Retail Pharmacies
Global osteoporosis treatment market segmentation, by region:
- North America
- Asia Pacific
- Latin America
- Middle East & Africa
- Teva Pharmaceutical Industries Ltd.
- Amgen Inc.
- Dr Reddy's Laboratories
- Mylan Inc.
- Pfenex Inc.
- Eli Lilly and Company
- Asahi Kasei Corporation
- Hoffmann La Roche
- EffRx Pharmaceuticals SA
- Novartis AG
Request for TOC
Request for Customization
Don't just take our word. We are trusted by these great companies!